ZMS-11743-94735
1 vaccination
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 376 / TN
- Registered
- 2022-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-21
Registered in v-safe
-
2022-01-21
Dose 1 — Pfizer-BioNTech
-
2022-01-21
Health check-in — day 0, dose 1Feeling: Fair · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-01-22
Survey response — days 1–6 daily, dose 1MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolFree text: Tested positive for covidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-21 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 1
Systemic reaction (other): Tested positive for covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release